The importance of early detection of cancer is well-recognized, and efforts to develop biomarkers of various cancers are underway at the National Cancer Institute.
In the case of glioblastoma, early detection is especially important because it will allow us to treat tumors without surgery. Studies have shown that surgical removal of glioblastoma can stimulate any cancer cells left behind to grow up to 75 percent faster than they did before surgery.
Our goal is to provide additional support to investigators engaged in early detection of glioblastoma using state-of-the art molecular techniques. We hope to be able to replace surgery with targeted therapy, truly making glioblastoma a manageable chronic condition.